Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration

NCT: NCT07725055 · NOT_YET_RECRUITING

NCT IDNCT07725055
StatusNOT_YET_RECRUITING
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts (OTHER)
First posted
Last updated

Brief Summary

Primary objective: \- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope. Secondary objectives: * To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑